Dr Edgardo Baracchini joins Xencor
This article was originally published in Scrip
Executive Summary
Xencor, a US company using Fc engineering for the discovery and development of next-generation antibodies, has named Dr Edgardo Baracchini chief business officer. He has more than 15 years' experience, having most recently served as senior vice-president of business development at Metabasis Therapeutics until its merger with Ligand Pharmaceuticals last year.